Companies
Vaccine doubles survival of deadly brain cancer
By Julie Steenhuysen
Font Scale: 
Posted 03 June 2008 @ 08:08 am GMT
A brain scan in an undated image. A cancer vaccine more than doubled the survival time of people with the most common and deadly type of brain tumor, U.S. researchers said on Monday. REUTERS/File
Article Tags 
brain cancer survival vaccine
Scientists pinpoint why some people become addictsPfizer, whose stock is at a 10-year low, is in need of a big win. "This is probably one of the biggest if not the biggest immunotherapy deals that has been made," Sampson said.
"If this works, I think there will be more investment in vaccines," he said.
About 22,000 malignant tumors of the brain or spinal cord will be diagnosed this year in the United States, and about 13,000 people will die from them, according to the American Cancer Society.
(Editing by Maggie Fox and Cynthia Osterman)
Next Page
Copyright 2006 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Most Popular Stories
Top Stories on Companies
- 1 RBS gets Chinese approval for Suzhou stake
- 2 BT cutting 10,000 jobs as part of costs drive
- 3 Kingfisher to double Polish arm as migrants return
- 4 UBS says infrastructure fund raises $1.5 billion
- 5 Lloyds TSB could face rival bid for HBOS
- 6 Ryanair earnings down 47 percent
- 7 John Lewis weekly store sales down 9.8 pct
|
|
